KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.
Tinsley SL, Chianis ERD, Shelley RA, Mall GK, Dhiman A, Baral G, Kothandaraman H, Thoma MC, English IA, Daniel CJ, Acosta LCS, Solorio L, Atallah Lanman N, Pasca di Magliano M, Narla G, Dykhuizen EC, Sears RC, Allen-Petersen BL.
Tinsley SL, et al. Among authors: dhiman a.
Oncogene. 2024 Oct 23. doi: 10.1038/s41388-024-03196-w. Online ahead of print.
Oncogene. 2024.
PMID: 39443726